Impact on Research
COVID-19 Vaccine Panel
On March 1, 2021, the Lymphoma Research Foundation convened an expert panel of medical and scientific advisors to discuss the current state of research regarding the COVID-19 vaccine and people with lymphoma. The panel discussed recommendations for oncologists caring for people with these cancers, as well as related scientific research and education programming. This white paper reflects the panel discussion and the state of research as of the date of the original panel meeting. Oncologists and other healthcare providers are encouraged to consult the most recent guidance from the Centers for Disease Control and Prevention (CDC) and other federal healthcare agencies when making treatment recommendations.
Download / Read the Proceedings of the COVID-19 Vaccine Panel white paper.
Patients should consult with their own healthcare providers when making treatment decisions and whether a COVID-19 vaccine might be appropriate. For additional information, members of the lymphoma community are also encouraged to visit the Lymphoma Research Foundation’s COVID-19 Learning Center at lymphoma.org/covid19 and/or contact the LRF Helpline at 800-500-9976 or helpline@lymphoma.org.
Panel Memebers
Andrew D. Zelenetz, MD, PhD
Panel Chair
Medical Oncologist and Medical Director, Quality Informatics
Memorial Sloan Kettering Cancer Center
Chair, Lymphoma Research Foundation Scientific Advisory Board
Ranjana Advani, MD
Saul A Rosenberg Professor of Lymphoma
Stanford Cancer Institute
Ash A. Alizadeh, MD, PhD
Associate Professor, Divisions of Oncology and Hematology
Stanford Cancer Institute
Lindsey R. Baden, MMSc, MD
Associate Professor of Medicine, Harvard Medical School
Associate Professor and Director of Clinical Research Department of Medicine, Infectious Diseases
Brigham and Women’s Hospital
Nilanjan Chatterjee, PhD
Bloomberg Distinguished Professor Department of Biostatistics, Bloomberg School of Public Health Department of Oncology, School of Medicine
Johns Hopkins University
Andrew M. Evens, DO, MSc, FACP
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey
Director, Lymphoma Program, Division of Blood Disorders and
Medical Director, Oncology Service Line, RWJ Barnabas Health
Leo I. Gordon MD, FACP
Abby and John Friend Professor of Cancer Research
Professor of Medicine
Co-Director, Hematologic Malignancy Program Medical
Director, John and Lillian Mathews Cellular Therapy Laboratory
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Thomas M. Habermann, MD
Professor of Medicine Consultant, Division of Hematology
Mayo Clinic, Rochester
John P. Leonard, MD
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Senior Associate Dean for Innovation and Initiatives Executive
Vice-Chair, Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medicine
Izidore S. Lossos, MD
Professor of Medicine Director, Lymphoma Program
Head, Hematological Malignancies Site Disease Group
Sylvester Comprehensive Cancer Center University of Miami
Peter Martin, MD
Associate Professor of Medicine Chief, Lymphoma Program
Weill Cornell Medicine
Sonali M. Smith, MD
Elwood V. Jensen Professor in Medicine
Chief, Section of Hematology/Oncology University of Chicago Medicine
Chair-Elect, Lymphoma Research Foundation Scientific Advisory Board
Barbara Pro, MD
Professor of Medicine, Division of Hematology and Oncology
Clinical Director, Lymphoma Program
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Michael Satlin, MD
Associate Professor of Medicine
William Randolph Hearst Foundation Clinical Scholar in Microbiology and Infectious Diseases
Weill Cornell Medicine
Kerry J. Savage, MD, MSc
Professor, Medical Oncology University of British Columbia
BC Cancer Agency
Laurie H. Sehn MD, MPH
Chair, Lymphoma Tumour Group
BC Cancer Centre for Lymphoid Cancer
Clinical Professor of Medicine Division of Medical Oncology
University of British Columbia
Adrian Wiestner, MD, PhD
Senior Investigator, Laboratory of Lymphoid Malignancies
National Heart, Lung, and Blood Institute National Institutes of Health